These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10490808)
1. Serum glucagon concentration and hyperinsulinaemia influence renal haemodynamics and urinary protein loss in normotensive patients with central obesity. Solerte SB; Rondanelli M; Giacchero R; Stabile M; Lovati E; Cravello L; Pontiggia B; Vignati G; Ferrari E; Fioravanti M Int J Obes Relat Metab Disord; 1999 Sep; 23(9):997-1003. PubMed ID: 10490808 [TBL] [Abstract][Full Text] [Related]
2. Hyperinsulinemia and glucagon serum concentrations influence renal hemodynamics and urinary protein loss in normotensive patients with central obesity. Solerte SB; Fioravanti M; Severgnini S; Rondanelli M; Precerutti S; Vignati G; Ferrari E Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S122-3. PubMed ID: 10997627 [No Abstract] [Full Text] [Related]
3. Insulin resistance underlies the elevated cardiovascular risk associated with kidney disease and glomerular hyperfiltration. Adeva-Andany MM; Fernández-Fernández C; Carneiro-Freire N; Castro-Quintela E; Pedre-Piñeiro A; Seco-Filgueira M Rev Cardiovasc Med; 2020 Mar; 21(1):41-56. PubMed ID: 32259903 [TBL] [Abstract][Full Text] [Related]
4. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Scaglione R; Ganguzza A; Corrao S; Parrinello G; Merlino G; Dichiara MA; Arnone S; D'Aubert MD; Licata G Int J Obes Relat Metab Disord; 1995 Jun; 19(6):403-9. PubMed ID: 7550525 [TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Eidemak I; Feldt-Rasmussen B; Kanstrup IL; Nielsen SL; Schmitz O; Strandgaard S Diabetologia; 1995 May; 38(5):565-72. PubMed ID: 7489839 [TBL] [Abstract][Full Text] [Related]
6. Effects of hyperglycaemia and hyperinsulinaemia on plasma amino acid levels in obese subjects with normal glucose tolerance. Marchesini G; Bianchi G; Rossi B; Muggeo M; Bonora E Int J Obes Relat Metab Disord; 2000 May; 24(5):552-8. PubMed ID: 10849575 [TBL] [Abstract][Full Text] [Related]
8. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971 [TBL] [Abstract][Full Text] [Related]
10. Stimulatory effect of insulin on tubular sodium reabsorption in normotensive subjects with a positive family history of hypertension. Herlitz H; Widgren B; Urbanavicius V; Attvall S; Persson B Nephrol Dial Transplant; 1996 Jan; 11(1):47-54. PubMed ID: 8649652 [TBL] [Abstract][Full Text] [Related]
11. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males. Hautanen A; Räikkönen K; Adlercreutz H J Intern Med; 1997 Jun; 241(6):451-61. PubMed ID: 10497620 [TBL] [Abstract][Full Text] [Related]
12. Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding. van Citters GW; Kabir M; Kim SP; Mittelman SD; Dea MK; Brubaker PL; Bergman RN J Clin Endocrinol Metab; 2002 Nov; 87(11):5191-8. PubMed ID: 12414891 [TBL] [Abstract][Full Text] [Related]
13. Combined renal effects of overweight and hypertension. Ribstein J; du Cailar G; Mimran A Hypertension; 1995 Oct; 26(4):610-5. PubMed ID: 7558220 [TBL] [Abstract][Full Text] [Related]
14. Elevation of plasma leptin concentrations in obese hyperinsulinaemic hypothyroidism before and after treatment. Kautzky-Willer A; Ludwig C; Nowotny P; Roden A; Huemer C; Widhalm K; Vierhapper H; Waldhäusl W; Roden M Eur J Clin Invest; 1999 May; 29(5):395-403. PubMed ID: 10354196 [TBL] [Abstract][Full Text] [Related]
15. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Wuerzner G; Pruijm M; Maillard M; Bovet P; Renaud C; Burnier M; Bochud M Am J Kidney Dis; 2010 Aug; 56(2):303-12. PubMed ID: 20538392 [TBL] [Abstract][Full Text] [Related]
16. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension. Iannello S; Campione R; Belfiore F Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544 [TBL] [Abstract][Full Text] [Related]
18. Hyperviscosity and microproteinuria in central obesity: relevance to cardiovascular risk. Solerte SB; Fioravanti M; Pezza N; Locatelli M; Schifino N; Cerutti N; Severgnini S; Rondanelli M; Ferrari E Int J Obes Relat Metab Disord; 1997 Jun; 21(6):417-23. PubMed ID: 9192223 [TBL] [Abstract][Full Text] [Related]
19. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance. Hussein MS; Abushady MM; Refaat S; Ibrahim R Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596 [TBL] [Abstract][Full Text] [Related]
20. Glomerular hemodynamics in severe obesity. Chagnac A; Weinstein T; Korzets A; Ramadan E; Hirsch J; Gafter U Am J Physiol Renal Physiol; 2000 May; 278(5):F817-22. PubMed ID: 10807594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]